Cancer & SURVIVEiT News
Category Filter:
A Liver Cancer Survivor Shares Her Story
Liver cancer has been slowly on the rise in the U.S. over the past decades. “Liver cancer is the growth and spread of unhealthy cells in the liver. Cancer that…
10-Year Retrospective Study Shows Improvements in Liver Cancer Survival Rates
Hepatocellular carcinoma is the most common kind of primary liver cancer. Many people who have this type of tumor of the liver have previous liver disease. The tumour can affect…
Combination Therapy Can Improve Outcome For Advanced Liver Cancer
Liver cancer research is in the spotlight this month. As Liver Cancer Awareness month goes on, we’re seeing more and more articles about liver cancer symptoms and treatments, liver cancer…
FDA approves cabozantinib for hepatocellular carcinoma
FDA approves cabozantinib for hepatocellular carcinoma On January 14, 2019, the Food and Drug Administration approved cabozantinib (CABOMETYX, Exelixis, Inc.) for patients with hepatocellular carcinoma (HCC) who have been previously…
FDA grants accelerated approval to pembrolizumab for hepatocellular carcinoma
FDA grants accelerated approval to pembrolizumab for hepatocellular carcinoma On November 9, 2018, the Food and Drug Administration granted accelerated approval to pembrolizumab (KEYTRUDA, Merck & Co., Inc.) for patients…